Dextromethorphan Plus Quinidine Helps Quell Agitation

A phase II randomized trial shows that dextromethorphan in combination with quinidine may have potential for treatment of agitation in patients with Alzheimer's disease. The results are particularly notable, say the authors, because this is the first trial in dementia to employ a sequential parallel comparison design to help offset the “placebo effect.”
Source: Caring for the Ages - Category: Health Management Authors: Source Type: news